연구

연구업적

최근 5년 연구업적 현황
연도 2023년 2022년 2021년 2020년 2019년
SCI 논문
발표편수
책임 173편 163편 184편 135편 144편
공동 120편 115편 136편 168편 167편
합계 293편 278편 320편 303편 311편
2191. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
Kim H, Goo JM, Suh YJ, Park CM, Kim YT
Eur Radiol. 2019 Mar;29(3):1586-1594 Link
2190. Identification of a Novel Fusion Gene, FAM174A-WWC1, in Early-Onset Colorectal Cancer: Establishment and Characterization of Four Human Cancer Cell Lines from Early-Onset Colorectal Cancers.
Kim SC1, Shin R2, Seo HY1, Kim M3, Park JW3, Jeong SY4, Ku JL5.
Transl Oncol. 2019 Sep;12(9):1185-1195. doi: 10.1016/j.tranon.2019.05.019. Epub 2019 Jun 20. Link
2189. Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line.
Kim SC1,2, Shin YK1, Kim SW3,4, Seo HY1,2, Kwon W3,4, Kim H3,4, Han Y3,4, Lee JO1, Jang JY3,4, Ku JL1,2.
Pancreas. 2019 Nov/Dec;48(10):1285-1293. doi: 10.1097/MPA.0000000000001420. Link
2188. Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation.
Kim BK, Kang HJ, Hong KT, An HY, Choi JY, Lee JS, Park SS, Shin HY.
Transpl Infect Dis.21(6):e13182. Link
2187. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
Choi JY, Kang HJ, Hong KT, Hong CR, Lee YJ, Park JD, Phi JH, Kim SK, Wang KC, Kim IH, Park SH, Choi YH, Cheon JE, Park KD, Shin HY.
Int J Clin Oncol.24(12):1515-1525. Link
2186. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
Kim BK, Hong KT, Kang HJ, An HY, Choi JY, Hong CR, Park KD, Lee DS, Shin HY.
J Pediatr Hematol Oncol.41(5):e336-e337. Link
2185. Successful haploidentical transplantation with post-transplant cyclophosphamide for activated phosphoinositide 3-kinase δ syndrome.
Hong CR, Lee S, Hong KT, Choi JY, Shin HY, Choi M, Kang HJ.
J Allergy Clin Immunol Pract.7(3):1034-1037. Link
2184. Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.
Chung H, Hong KT, Lee JW, Rhee SJ, Kim S, Yoon SH, Yu KS, Kang HJ.
Bone Marrow Transplant.54(2):284-292. Link
2183. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.
Shin YJ1,2, Kim Y1,3, Wen X1,3, Cho NY1,2, Lee S4, Kim WH3, Kang GH5,6.
Clin Epigenetics. 2019 May 14;11(1):77. doi: 10.1186/s13148-019-0661-x. Link
2182. p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Oh HJ1,2, Bae JM1,2, Wen X2, Jung S2, Kim Y1,2, Kim KJ2, Cho NY2, Kim JH1,2, Han SW3, Kim TY3, Kang GH4,5.
Br J Cancer. 2019 Apr;120(8):797-805. doi: 10.1038/s41416-019-0429-2. Epub 2019 Mar 21. Link